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Effi  cient adaptive immunity necessitates the 
encounter of exogenous antigens and rare 
antigen-specifi c immune cells in specialized 
microenvironments within the secondary lym-
phoid organs (SLOs; reference 1). The antigens 
are classically carried into the SLOs from the 
periphery by APCs. The cells of the adaptive 
arm of the immune system, particularly naive 
T cells, continue to recirculate via blood through 
the SLOs until they encounter their cognate 
antigen (2). The recognition of a cognate antigen 
by a T cell receptor in the context of MHC 
and with appropriate costimulation induces pro-
found changes in T cell behavior, which signify 
the initiation of the adaptive immune response.
According to the current paradigm, the 
two distinct migratory paths of APCs and 
T cells, which converge in the T cell zones 
of SLOs, are governed by the chemokine re-
ceptor CCR7 (3). CCR7 is highly expressed 
on mature DCs as well as on naive and central 
memory T cells (4), whereas its two chemokine 
ligands CCL19 and CCL21 are produced con-
stitutively in the lymphoid organs and lym-
phatic vessels. The cardinal role of CCR7 in 
the homing and positioning of naive T cells 
and DCs in the SLOs and the ensuing eff ect on 
the immune response are illustrated by the pro-
foundly disrupted cellular architecture of the 
SLOs in CCR7-defi cient (CCR7 KO) mice. 
Consequently CCR7 KO mice were shown to 
have a reduced ability to mount primary im-
mune responses (5). However, recent studies 
indicate that adaptive immunity may develop 
through alternative pathways that do not in-
volve CCR7. Peripheral antigens can diff use in 
soluble form into the SLOs, where after acqui-
sition, processing, and presentation by the resi-
dent APCs, they can induce immune responses 
(6, 7). Also, alternative chemoattractant recep-
tors may be substituting for CCR7 in inducing 
the homing of T cell and APC subsets into the 
SLOs (8–13).
Therefore, we initially explored the contribu-
tion of CCR7 to the development of T cell im-
munity by setting up skin contact hypersensitivity 
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(CHS) reactions in CCR7 KO mice. We show that T cell–
mediated immunity to contact antigens develops in the ab-
sence of CCR7; moreover, the responses in CCR7 KO mice 
exceed those seen in WT BALB/c mice. The exacerbated 
CHS response in CCR7 KO mice is ameliorated by the trans-
fer of WT CD4+ CD25+ regulatory T cells (T reg cells). This 
incriminates insuffi  cient T reg cell function in the enhanced 
CHS in CCR7 KO mice and suggests that T reg cells may 
 require CCR7 for their in vivo suppressive activity. Indeed, 
FoxP3+ T reg cells express CCR7 and use it to home into 
LNs, where they expand upon antigen stimulation and sup-
press eff ector cell responses. CCR7 KO T reg cells fail to 
 localize to LNs and to inhibit specifi c eff ector cell response. 
Additionally, CCR7 KO T reg cells have an approximately 
twofold reduced capacity to protect in a transfer model of in-
fl ammatory bowel disease (IBD). This demonstrates that on 
one hand, CCR7 can be bypassed for the induction of immu-
nity, but its expression by T reg cells is required for their 
 migration into the LNs and contributes to their suppressive 
function in vivo.
RESULTS
Augmented CHS in CCR7 KO mice
To evaluate the contribution of CCR7 to antigen sensitiza-
tion and the subsequent immune response, we used a model 
for epicutaneous CHS in CCR7 KO mice. WT and CCR7 
KO mice were painted with oxazolone on the shaved 
abdomen and challenged by applying this hapten onto the 
ears every second day for fi ve times starting on day 7 after 
the sensitization. The CHS lesions observed in CCR7 KO 
mice were more severe than in WT mice. The diff erence 
in the ear thickness between CCR7 KO and WT mice be-
came apparent after the third challenge (Fig. 1 A). After the 
last challenge, we measured an almost fi vefold diff erence 
in auricular weights of the CCR7 KO (35.6 ± 3.5 mg) 
and WT mice (7.5 ± 4.0 mg), and an obvious skin fl are 
was observed in CCR7 KO mice (Fig. 1 B). The histo-
logical evaluation revealed an augmented leukocyte infi l-
trate in the ears of CCR7 KO mice (Fig. 1 C) containing 
large numbers of CD3+ T cells (Fig. 1 E). The extent of 
T cell responses is known to be controlled by T reg cells. 
To investigate whether the enhanced CHS in CCR7 KO 
mice may be the result of impaired T reg cell function, we 
transferred WT CD4+ CD25+ T reg cells into CCR7 KO 
recipients 1 d before their sensitization. In mice reconsti-
tuted with WT T reg cells, we observed a signifi cant re-
duction (P > 0.001) of ear thickness, resulting in lesions 
of similar overall severity as seen in WT mice (Fig. 1 A). 
To study whether CCR7 KO mice have a generally en-
hanced immune response, including to noncontact antigens, 
we compared tetanus toxoid–induced ex vivo splenocyte 
proliferation in CCR7 KO and WT mice after their immu-
nization. We found that CCR7 KO mice have consistently 
higher spontaneous and tetanus toxoid–induced responses 
than WT mice (Fig. S1, available at http://www.jem.org/
cgi/content/full/jem.20061405/DC1).
CCR7 is expressed by FoxP3+ T reg cells and affects 
their tissue distribution
We used fl ow cytometry to study the surface expression of 
CCR7 by FoxP3+ CD4+ CD25+ T reg cells in diff erent 
Figure 1. CCR7 KO mice show enhanced CHS reaction to oxazolone. 
(A) The ear thickness before and after fi ve repeated oxazolone challenges 
in sensitized mice; data are expressed as mean differences between the 
hapten- and vehicle-challenged ears. From the third challenge onwards, 
CCR7 KO mice (white symbols; n = 19) have an enhanced ear swelling 
compared with WT mice (black symbols; n = 10). The augmented ear 
swelling in CCR7 KO was reversed by the transfer of 5 × 105 naive WT 
T reg cells (dotted line; n = 7). Inset table shows the area under the curve 
values and their statistical analysis (Student’s t test). Error bars represent 
SEM. (B) After the last challenge, the difference between WT and CCR7 KO 
mice can be observed as an enhanced fl are. (C and D) Microscopically, the 
CHS lesions contain a massive mononuclear infi ltrate in CCR7 KO mice (C) 
in comparison with a moderate infi ltrate in WT mice (D). (E and F) CD3 
immunostaining of the CHS lesions in CCR7 KO (F) and WT mice (E) 
 revealed that the infi ltrate consists mostly of CD3+ cells. Bars, 50 μm. 
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 tissues of WT mice. As shown in Fig. 2, almost all T reg cells 
in the blood and a high proportion of them in SLOs bear 
CCR7. To examine whether CCR7 expression aff ects the 
tissue distribution of FoxP3+ T reg cells, their numbers in 
WT and CCR7 KO mice were compared. Single-cell suspen-
sions from the blood, spleen, and peripheral LNs (inguinal 
and axillary) were immunostained, and cell numbers were as-
sessed in fl ow cytometry.
In comparison with WT mice, the LNs of CCR7 KO 
mice contained only very few CD4 T cells (5), including 
FoxP3+ T reg cells (Fig. 3 A). In contrast, the numbers of 
CD4+ and FoxP3+ T cells were increased in the spleen of 
CCR7 KO mice (Fig. 3 B), whereas in the blood, only CD4+ 
T cells were elevated (Fig. 3 C). This demonstrates a skewed 
distribution of FoxP3+ T cells between blood and the SLOs 
of CCR7 KO mice, including their relative frequency (Fig. 
S2 D, available at http://www.jem.org/cgi/content/full/
jem.20061405/DC1). In comparison with WT mice, the per-
centage of T reg cells is slightly elevated in LNs of CCR7 
KO mice. However, it is likely that it is not the percentage of 
T reg cells in LNs that determines their utility or lack of it but 
their ability to localize into functional microenvironments. 
Memory T cells (CD4+ CD44high CD62Lneg CD45RBlow) are 
relatively enriched in peripheral LNs of CCR7 KO mice 
(Fig. S2 E). Also, the proportion of CD4-activated cells 
(defi ned as CD4+ CD25+ CD44high FoxP3neg) is higher in 
both resting and CHS- draining LNs of CCR7 KO mice in 
comparison with their WT counterparts (Fig. S2 F).
Immunofl uorescent staining of LNs in CCR7 KO mice 
confi rmed their disrupted architecture and altered cell distri-
bution, also aff ecting FoxP3+ T cells (Fig. 3 D). Neverthe-
less, numerous contacts between T cells and DCs take place 
in the LNs of CCR7 KO mice, especially in the LNs drain-
ing CHS lesions (Fig. 3 D). 
Figure 2. CCR7 is expressed by FoxP3+ CD4+ CD25+ T reg cells. 
Flow cytometric analysis of peripheral blood and single-cell suspensions 
of spleen and inguinal LNs of WT mice revealed that CD4+ CD25+ T reg 
cells coexpress FoxP3 and CCR7. Dot plots of FoxP3 and CCR7 staining 
(bottom) are gated on the CD4+ CD25+ T cells shown in the top panel. 
Numbers indicate the percentage of cells in each quadrant.
Figure 3. Numbers of CD4+ and FoxP3+ cells in the peripheral LN, 
blood, and spleen of WT and CCR7 KO mice. (A) Few CD4+ and 
FoxP3+ cells can be found in the peripheral LNs of CCR7 KO mice (white 
circles) compared with WT mice (black circles). (B and C) In contrast, both 
populations are increased in the spleen (B), whereas in blood, only the 
CD4+ cells are increased, and FoxP3+ cells are reduced (n = 4; C). Hori-
zontal lines represent the mean values. (D) CD3+ and FoxP3+ T cells show 
altered distribution in retroauricular LNs of CCR7 KO mice compared with 
normal architecture in WT mice. Organized T cell zones of WT LNs are 
shown. This microarchitecture cannot be found in CCR7 KO mice, where 
diffuse T cell distribution is observed. Bars, 200 μm.
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Because CCR7 may contribute to T cell selection in the 
thymus (14–16), we compared the thymic distribution of 
FoxP3+ T cells in CCR7 KO and WT mice. We could not 
observe any numerical diff erences in CCR7 KO mice; how-
ever, FoxP3+ cells appeared not only in the medulla but also 
in sparse foci in cortical areas (Fig. S3, available at http://www
.jem.org/cgi/content/full/jem.20061405/DC1). In summary, 
CCR7 is highly expressed on FoxP3+ CD4+ CD25+ T reg 
cells and aff ects their localization in diff erent organs.
CD4+ CD25+ T reg cells from CCR7 KO mice are unable 
to control the proliferation of CD4 T cells in vivo
To investigate whether CCR7 on T reg cells is required for 
their regulatory function in vivo, we studied the responses of 
TCR transgenic T cells after their adoptive transfer. First, 
CD4+ CD25+ T reg cells were isolated from DO11.10 mice, 
CFSE labeled, and injected into WT mice. 24 h after the 
transfer, the animals were injected with OVA into the 
footpad. The draining and counterlateral popliteal LNs 
were excised 72 h after the OVA injection, and the fl uores-
cence intensity of CFSE-labeled CD4+ CD25+ T reg cells 
was analyzed.
T reg cells from DO11.10 donors entered both LNs but 
expanded only in the draining LN as seen by their CFSE di-
lution profi le (Fig. 4 A). In contrast, hardly any T reg cells 
from DO11.10 × CCR7 KO animals could be found in the 
draining LN (Fig. 4 A). The impact of impaired LN homing 
of CCR7 KO T reg cells was studied in the following co-
transfer experiment. OVA TCR transgenic CD4+ T cells 
were CFSE labeled and injected i.v. either alone or in com-
bination with unlabeled CD4+ CD25+ T reg cells from ei-
ther DO11.10 mice or DO11.10 × CCR7 KO mice. The 
recipient mice were again challenged with OVA in the foot-
pad and analyzed 72 h later. The transferred CD4+ T cells 
proliferated in response to their cognate antigen (Fig. 4 B) 
and up-regulated the expression of CD25 (Fig. 4 B). Co-
transferred DO11.10 T reg cells but not DO11.10 × CCR7 
KO T reg cells reduced the number of CD4+ T cells and 
blocked the CD25 expression of CD4+ T cells (Fig. 4 B). 
Mean numbers of CFSE-positive cells per draining popliteal 
LN (n = 4) are shown in Fig. 4 C. The overall number of 
CD4+ T cells in LNs regulated by WT T reg cells is signifi -
cantly diminished (P > 0.01), which is consistent with 
their reduced proliferation. However, we cannot formally 
exclude the possibilities that WT T reg cells also induce the 
death of CD4+ T cells as suggested previously (17) or cause 
the reduction in their LN recruitment or the increase in 
their departure.
In conclusion, T reg cells from DO11.10 × CCR7 KO 
mice were unable to enter the draining LNs after antigenic 
challenge and, therefore, failed to suppress the expansion and 
eff ector diff erentiation of CD4+ T cells. However, CCR7 
itself is not required for the suppressive function of T reg 
cells, as demonstrated by the classic in vitro suppression assay. 
Polyclonal CD4+ T cells from WT mice were stimulated 
in vitro with anti-CD3 mAb in the presence or absence of 
Figure 4. Adoptively transferred CCR7 KO T reg cells cannot sup-
press the antigen-induced expansion of TCR transgenic T cells. 
(A) 5 × 105 transferred CFSE-labeled T reg cells from DO11.10 mice enter 
LNs and, after antigen stimulation, expand in draining popliteal LNs and 
not in counterlateral LNs. Only a few T reg cells from DO11.10 × CCR7 KO 
can be detected in the LNs after their transfer. (B) Antigen-induced ex-
pansion of 5 × 105 CFSE-labeled DO11.10 CD4+ Th cells; their concurrent 
CD25 up-regulation is suppressed by the cotransfer of DO11.10 T reg cells 
but not DO11.10 × CCR7 KO T reg cells. Th cells regulated by WT T reg 
cells divide approximately one generation less in comparison with two 
other groups (dot plots). In unregulated and CCR7 KO T reg cell–regulated 
groups, the majority of Th cells are in generations three, four, and fi ve, 
whereas the majority of Th cells regulated by WT T reg cells are in genera-
tions two, three, and four; their overall numbers are also reduced (histo-
grams). (C) Statistical evaluation of the data in B (n = 4). The cotransfer 
of T reg cells from DO11.10 mice reduced (**, P < 0.01) the mean total 
number of CFSE+ T cells in the draining popliteal LNs, whereas the co-
transferred DO11.10 × CCR7 KO T reg cells showed no effect. Error bars 
represent SEM.
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CD4+ CD25+ T reg cells from WT or CCR7 KO mice. Af-
ter 72 h, the CFSE profi le of the CD4+ responder cells was 
characterized. Both T reg cell populations demonstrated 
comparable suppression of CD4 T cell proliferation (Fig. 5).
CD4+ CD25+ T reg cells from CCR7 KO mice enter 
peripheral tissues
There are two potential sites where CD4+ CD25+ T reg cells 
can suppress immune reactions: the LNs, as shown in the 
previous section, and peripheral tissues. To examine whether 
CCR7 KO T reg cells are able to enter infl amed skin, we in-
vestigated the CHS ear lesions of CCR7 KO mice for the 
presence of FoxP3+ T reg cells. Unchallenged and challenged 
ears from both WT and CCR7 KO mice were stained with 
antibodies against CD3, FoxP3, and CD11c. Increased num-
bers of FoxP3+ T reg cells appeared within the infl amed ears 
of CCR7 KO mice in comparison with WT mice (Fig. 6). It 
was recently shown that a subpopulation of CD4+ CD25+ T 
reg cells that enters peripheral sites expresses high levels of the 
integrin marker CD103 (18). We compared the expression of 
CD103 on T reg cells in CCR7 KO and WT mice. A high 
proportion of the FoxP3+ CD4+ CD25+ T reg cells from 
CCR7 KO mice show CD103 expression in contrast to only 
a small subpopulation in WT mice (Fig. 7). In addition, we 
observed more CCR2+ FoxP3+ T cells and increased levels 
of CD44 on T reg cells from CCR7 KO mice (Fig. 7). Thus, 
we identifi ed a pattern of adhesion molecule and chemokine 
receptor expression on CCR7 KO T reg cells, which may 
explain their ability to enter the CHS lesions. However, it is 
clear that their presence in these lesions is not suffi  cient to 
control the development of the pathological changes (Fig. 1), 
indicating that optimal regulation requires the entry of T reg 
cells into the LN.
CCR7 KO T reg cells are ineffi cient in controlling IBD
As T reg cells from CCR7 KO mice were unable to suppress 
the expansion of CD4+ T cells in the draining LNs, we ex-
plored their potential to control the induction of experimen-
tal IBD. CD4+ CD25neg T cells (T helper cell [Th cell]) from 
either WT or CCR7 KO mice were injected into SCID 
mice with or without WT or CCR7 KO CD4+ CD25+ 
T reg cells. The eff ect of two diff erent ratios of T reg cells 
and Th cells was investigated (1:1 and 1:2). The transfer of WT 
and CCR7 KO Th cells lead to a comparable weight loss in 
SCID mice, albeit with a diff erent time course. A delayed 
disease onset was observed after the transfer of CCR7 KO 
Th cells (Fig. 8). IBD induced by WT Th cells was prevented 
by WT T reg cells in both ratios studied, as shown by weight 
curves (Fig. 8 A) and histological evaluation of the lesions at 
the end of the experiment (Fig. 9 A and Fig. S4 A, available 
at http://www.jem.org/cgi/content/full/jem.20061405/DC1). 
CCR7 KO T reg cells in both ratios used were less potent 
in preventing the weight loss in comparison with their WT 
counterparts (Figs. 8 A, 9A, and S4 A). A cell dose de pendency 
of the suppressive eff ect could be observed using both WT 
and CCR7 KO T reg cells. IBD induced by CCR7 KO Th 
Figure 5. In vitro function of CD4+ CD25+ T reg cells is not 
dependent on CCR7 expression. Polyclonal CD4+ T cells were stained with 
CFSE and stimulated with anti-CD3 mAb for 72 h in the presence of 
CD4+ CD25+ T reg cells from either WT or CCR7 KO mice. Both T reg cell 
populations show similar in vitro suppression of T cell proliferation in a 
dose-dependent manner (a 1:1 ratio is shown).
Figure 6. FoxP3+ T reg cells enter the CHS lesions of CCR7 KO 
mice. Immunofl uorescence in the unchallenged (left) ears and oxazolon-
challenged (right) ears of WT and CCR7 KO mice. The challenged ears of 
CCR7 KO mice contain an elevated number of CD3+ FoxP3+ T reg cells in 
comparison with WT mice. One representative ear sample out of 10 mice 
per group is shown. Bars, 200 μm.
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cells was also prevented by WT T reg cells. Again, CCR7 
KO T reg cells were less potent regulators (Figs. 8 B, 9B, 
and S4 B), but, for these cells, no dose dependency was 
 observed. In conclusion, in the SCID transfer model of IBD, 
the induction of disease is not dependent on CCR7. How-
ever, CCR7 is required for the optimal regulation of IBD.
D I S C U S S I O N 
Close encounters of APCs and naive T cells in the SLOs are 
essential for the effi  cient initiation of an immune response. 
CCR7 and its ligands CCL19 and CCL21 orchestrate the 
homing of mature DCs and T cell subsets into the T cell zones 
of the SLOs. Therefore, this chemokine pathway plays an im-
portant role in the eff ective induction of adaptive immunity. 
In this study, we show that immune responses can also 
develop in the absence of CCR7, including a CHS re action 
to a hapten, a response to bacterial gut fl ora that manifests 
in an experimental IBD, and recall immunity to an injected 
T cell antigen.
These fi ndings are rather surprising in light of a com-
pletely scrambled SLO architecture in CCR7 KO mice (5). 
In contrast to our current fi ndings, the CCR7 KO mice were 
initially described to exhibit a mitigated CHS (5). This may 
be the result of the diff erent haptens used and because the 
previous study evaluated the CHS lesions in CCR7 KO mice 
possibly too early to see a response (5). We show now that 
the development of immunity in these mice takes a retarded 
course. In complete agreement with our fi ndings, a delayed 
time course but increased severity of CHS and augmented 
antigen-induced T cell proliferation have been seen in the 
mutant mouse strain plt (19). Plt mice do not express two out 
of the three known CCR7 ligands (CCL19 and CCL21-Ser) 
and, similar to CCR7 KO mice, lack the normal SLO orga-
nization because of a defect in DC and T cell homing (20, 21). 
However, until now, the ability of plt mice to mount im-
mune responses and their apparent diff erence with the 
 phenotype described for CCR7 KO mice (5, 19) have been 
attributed to the compensatory presence of one CCL21 gene, 
CCL21-Leu, which is expressed in the lymphatic endothe-
lium of plt mice (22). Additionally, CCR7 was shown not to be 
essential for the establishment of functional T cell immunity 
to viral infection: CCR7 KO mice can clear lymphocytic chorio-
meningitis virus and develop cytotoxic and memory T cell 
responses against it (23).
So how is adaptive immunity induced in CCR7 KO 
mice? We can only speculate whether either DCs and T cells 
themselves or only their CCR7-mediated migratory paths 
are dispensable for immune responses. Recently, both epi-
dermal DCs (Langerhans cells) and T cells were shown to be 
completely superfl uous for the induction of CHS reactions 
(24, 25). Curiously, the absence of Langerhans cells leads 
even to an enhanced CHS. This is consistent with the notion 
that regulation of CHS but not its induction is dependent 
on antigen presentation by these cells (24). In the absence of 
T cells, the Ly49C-I+ NK cells can substitute for them com-
pletely in the induction of CHS to at least three diff erent 
haptens, including oxazolone (25). In this study, an anti–L-
selectin antibody (Mel-14) blocked the NK cell homing into 
Figure 7. FoxP3+ T reg cells in CCR7 KO mice have a higher 
expression of CD44 and an increased frequency of CD103+ and 
CCR2+ subpopulations. Histograms of data acquired from the blood, 
spleen, and peripheral LNs are shown. 104 FoxP3+ T cells are depicted 
per histogram. In comparison with CCR7 KO mice (white histograms), 
WT mice (black histograms) have comparatively smaller subpopula-
tions of CD103+ and CCR2+ T reg cells. CCR7 KO T reg cells also 
 express higher levels of CD44. One out of four measurements on cells 
from different mice are shown. Numbers indicate the percentages of 
positive cells.
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the draining LN and impaired the CHS induced by these 
cells. This implies that for the induction of their antigen re-
sponsiveness, NK cells, just like T cells, respond to the anti-
gens in the LN and may require antigen presentation by 
APCs. It is not clear whether NK cells use CCR7 or other 
chemokine receptors to home into the LNs.
Despite the lack of normal microanatomical organiza-
tion, the SLOs of CCR7 KO mice still contain T cells and 
DCs, several of which are in close contact with each other, 
as shown here. This suggests that in the absence of CCR7, 
other migratory molecules may replace CCR7 to allow T 
cells and DCs to enter SLOs. T cell subsets appear to exhibit 
diff erential dependency on CCR7 for their homing into the 
SLOs (26). It was shown that central memory T cells may use 
CXCR4 to home into the LNs (8). APC homing into the 
draining LNs can be induced in addition to the canonical 
CCR7 (27) also via CCR2, CCR8, and CXCR3 (11–13). 
However, to induce immunity, antigens do not have to be 
necessarily carried into the draining LNs by migrating DCs. 
During the initial phase of a peripheral antigen challenge, free 
soluble antigens are channeled via lymphatics and LN con-
duits to LN-resident DCs (7, 28), which can effi  ciently pro-
cess and present them (6). Additionally, massive antigenic 
stimulation may lead to the carry over of soluble antigen via 
blood into the spleen, where the necessary cellular players are 
present in suffi  cient numbers even in CCR7 KO mice.
Ultimately, we cannot answer the questions of how and 
where immunity is induced in CCR7 KO mice, but our 
Figure 8. Ineffective control of experimental IBD by CD4+ CD25+ 
CCR7 KO T reg cells. (A and B) The transfer of WT (A) or CCR7 KO (B) 
CD4 Th cells (black circles) into SCID mice induces weight loss, albeit with 
different kinetics. Disease induced by WT Th cells is prevented by the 
cotransfer of WT T reg cells in both ratios of 1:2 (black squares) and 
1:1 (black triangles), whereas CCR7 KO T reg cells in ratios 1:2 (white 
squares) and 1:1 (white triangles) were less effective than their WT 
counterparts. The regulatory effect for both WT and CCR7 KO T reg cells 
was cell dose dependent (A). IBD induced by CCR7 KO Th cells developed 
with a 1-wk delay and was completely prevented by WT T reg cells and to 
a lesser extent by CCR7 KO T reg cells. In the latter case, no cell dose 
dependency could be observed (B). The last data points of the curves were 
analyzed with one-way analysis of variance and Dunnett’s correction in 
comparison with untransferred control mice (**, P < 0.01). Error bars 
represent SEM.
Figure 9. Mean histological scores of IBD lesions. Histological 
scores were obtained by evaluating sections prepared from the descend-
ing colon of individual mice. Epithelial cell damage, architectural changes, 
neutrophil, and mononuclear cell infi ltrates as well as ulceration and 
granuloma formation were evaluated and scored blind independently of 
each other. Data are presented as box plots (n = 6 per group). Addition-
ally, micrographs are shown in Fig. S4 (available at http://www.jem.org/
cgi/content/full/jem.20061405/DC1). Data were analyzed with analysis of 
variance and Bonferroni correction to compare different groups. Apart 
from WT Th cells + WT T reg cells (2:1) compared with WT Th cells + KO 
T reg cells (1:1), all groups are signifi cantly different (P < 0.001; A). In B, 
only KO Th cells are signifi cantly different from other groups (P < 0.001). 
Error bars represent SEM.
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 results suggest a plausible explanation for why the immune 
responses in these mice take an exaggerated course. Our data 
unequivocally show that the counter-regulation of immun-
ity by CD4+ CD25+ T reg cells is critically dependent on 
CCR7. Confi rming previous results (29–32), we show that 
WT CD4+ CD25+ FoxP3+ T reg cells express CCR7. In 
addition, we demonstrate that WT T reg cells use it to home 
into the LN, where, upon antigen challenge, they proliferate 
and inhibit antigen-induced eff ector T cell responses, which 
is seen as a reduction in their numbers and CD25 expression. 
Unlike their WT counterparts, adoptively transferred CCR7 
KO T reg cells are ineffi  cient in homing to LNs and do not 
inhibit the antigen-induced generation of eff ector T cells. 
The contributions of CCR7 to T reg cell function were con-
fi rmed in our CHS model and also in our T cell transfer 
model of IBD. The latter has been classically used to study 
the immune regulation by T reg cells. In our studies, the co-
transferred CCR7 KO T reg cells were approximately half as 
eff ective as WT T reg cells in suppressing the induction of 
IBD in SCID hosts.
Such ineff ective T reg cell function may explain the fi nd-
ings that CCR7 KO mice spontaneously develop multiorgan 
autoimmunity, although not as severe as that observed in 
other susceptible strains (e.g., scurfy, NOD, and MLR/lpr). 
CCR7 KO mice have infl ammatory infi ltrates in the exo-
crine glands and stomach akin to those seen in Sjögren syn-
drome and Menetrier’s gastritis, respectively, as well as an 
overt glomerular autoimmune disease (16, 33, 34). Peripheral 
tissue lesions of ongoing immune reactions are considered to 
be important sites of CD4+ CD25+ T reg cell activity (35). 
Accordingly, a key regulatory role has been ascribed to the 
CD103+ subpopulation of T reg cells. These cells express in-
fl ammatory chemokine receptors, particularly CCR2 (36), 
allowing their migration into peripheral sites (18, 37). We 
found that the CD103+ CCR2+ CD44high subpopulation is a 
predominant T reg cell subset in CCR7 KO mice. This may 
explain why the CHS lesions in CCR7 KO mice contain 
large numbers of T reg cells. At present, their potential con-
tribution to the in situ regulation of CHS remains obscured. 
Their apparent inability to regulate in situ may be caused by 
the proinfl ammatory cytokine milieu present in the lesions. 
In particular, IL-6, which is overexpressed in CHS lesions of 
CCR7 KO mice (unpublished data), may directly inhibit the 
diff erentiation of T reg cells (38, 39) and convert the suppres-
sive molecular arsenal of T reg cells into a stimulatory one. 
IL-6 in combination with TGF-β, the main suppressive 
 cytokine of T reg cells, is a potent inducer of viciously pro-
infl ammatory Th17 cells (38–40).
There is an ongoing debate about whether diff erent T reg 
cell subpopulations are separate cell lineages or just represent 
diff erent maturation/activation stages of the same cell type 
(31, 41). In the latter case, it is possible that LN homing is 
part of the obligatory curriculum for all T reg cells and that 
the absence of CCR7 may hamper CD103+ T reg cell local-
ization into functional LN microenvironments. Thus, some-
time during their life span, CCR7-defi cient CD103+ T reg 
cells may not be able to receive hypothetical maturation, ac-
tivation, or armament signals from DCs. Subsequently, this 
may debilitate their regulatory function. CCR7 also orches-
trates the migratory steps required for T cell maturation in 
the thymus (14–16). As naturally occurring CD4+ CD25+ T 
reg cells are selected in the thymus (42), it is possible that 
CCR7 defi ciency compromises their thymic development. 
The dissimilar immunophenotype of T reg cells in CCR7 
KO and WT mice may suggest that the lack of CCR7 im-
pedes normal T reg cell development. However, the num-
bers of thymic FoxP3+ T reg cells are similar in WT and 
CCR7 KO mice, and, in both strains, T reg cell distribution 
in the medulla, the site of their selection (42), is similar too 
(Fig. S3 C). Immunostaining revealed sparse foci of FoxP3 
cells in the cortical areas of the thymus in CCR7 KO mice 
but not in WT (Fig. S3 C). Because of their low numbers, 
these would hardly aff ect the overall thymic output of T reg 
cells but may refl ect the requirement for CCR7 in the migra-
tory step of T reg cells from the cortex to the medulla. Fur-
thermore, we show that CCR7 KO T reg cells inhibit 
in vitro T cell proliferation to the same extent as their WT 
counterparts. This strongly suggests that the ineff ective regu-
lation by T reg cells observed in CCR7 KO mice is not 
caused by an intrinsic functional defect in these cells.
An additional factor may contribute to the enhanced cel-
lularity of infi ltrates in CHS lesions. CCR7 expression was 
shown to be required for the effi  cient departure of T cells 
from the peripheral sites (43, 44). We could confi rm these 
fi ndings (unpublished data) but argue that they may have 
only limited functional consequences because the lack of 
CCR7 can infl uence the tissue exit of only central memory 
cells (4) and a subpopulation of T reg cells (unpublished data). 
Among the lymphocyte subsets, these are the only cells 
known to express concurrently chemoattractant receptors 
that are required for tissue entry as well as CCR7.
The tightly regulated expression of various chemokines 
within the SLOs orchestrates the development and silencing 
of the immune responses by attracting and juxtapositioning 
functionally complementary cell types (45–48). Cumula-
tively, our data suggest that the CCR7-mediated positioning 
of T reg cells into the T cell zones is a prerequisite of their 
in vivo function. It also clearly indicates that at least in the 
models of immunity studied by us, LNs are the primary site of 
the suppressive activity of  T reg cells. This concept is supported 
by several recent studies describing T reg cells entering LNs 
and establishing close contacts with DCs (49–52). It is also 
likely that T reg cell contacts with DCs are required not only 
for the antigen-mediated activation, armament, and expan-
sion of T reg cells but may also infl uence the concurrent anti-
gen presentation by DCs to eff ector T cells and the successive 
development of immunity (49, 50). In addition to inducing 
the LN homing of T reg cells into functional SLO micro-
environments, CCR7 and its ligands may directly infl uence the 
quality of the synaptic interaction of T reg cells and DCs and 
bias its outcome. It was shown recently that DCs are deco-
rated by CCR7 ligands, which can induce the tethering of 
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T cells and infl uence their activation (53). Thus, the CCR7-
mediated DC–T reg cell synapse may constitute an important 
facet of the direct suppressive activity of T reg cells. The ex-
pression of CCR7 by human T reg cells (30, 32, 54) indicates 
that in humans, this receptor may also contribute in a similar 
fashion to the suppression of immunity.
We conclude that CCR7 plays a major role in setting up 
the functional clustering of T reg cells and DCs within the 
LNs. This cell contact is essential for the antigen-dependent 
T reg cell expansion and, possibly, is a part of their suppres-
sive function. Thus, CCR7 appears to be more important for 
the regulation of immunity than for its induction. Our fi nd-
ings question the utility of targeting CCR7 for the treatment 
of diseases with immune pathogenesis and suggest a potential 
use of CCR7 antagonists in breaking T reg cell–mediated 
immunosuppression.
MATERIALS AND METHODS
Animals. CCR7-defi cient mice that were described previously (5) have 
been crossed with BALB/c mice for 12 generations. The resulting strain, 
which is referred to as CCR7 KO, was crossed with DO11.10 mice to es-
tablish a TCR transgenic strain defi cient for CCR7 (DO11.10 × CCR7 
KO). The CCR7 KO, DO11.10, and DO11.10 × CCR7 KO mice were 
bred and housed under specifi c pathogen-free conditions at the animal facil-
ity of the Novartis Institutes for BioMedical Research (NIBR) and were 
used between the ages of 8 and 14 wk. Control BALB/c mice (referred to 
here as WT) and BALB/c SCID mice were purchased from Charles River 
Laboratories. All protocols were approved by both the NIBR and the mu-
nicipal animal welfare committees. Experiments were performed in accor-
dance with the laws of Austria.
CHS model. Mice were sensitized with 2% oxazolone/acetone on the 
shaved abdomen on day 1 and painted with 0.02% oxazolone/acetone on 
the inner side of the right ears on days 7, 9, 11, 14, and 16. Left ears were 
challenged by vehicle only and served as controls. CHS was assessed by mea-
suring ear swelling, which was determined before and 24 h after each chal-
lenge, and on day 17 by weighing the right and left ears (data expressed as ∆ 
between challenged and control ears) and evaluating them by histology and 
immunostaining according to standard procedures. To study the eff ect of 
WT regulation on the development of CHS lesions in CCR7 KO mice, 
T reg cells from WT mice were prepared as described below in Cell isolations 
and adoptive transfer and were injected at 5 × 105 cells/mouse into a group 
of CCR7 KO mice 1 d before their sensitization.
Flow cytometry and cell quantifi cation in FACS using counting 
beads. All antibodies were purchased from BD Biosciences except FoxP3-
FITC/PE (eBioscience) and KJ-126-APC (Caltag). MC-21 (anti–mouse 
CCR2) was a gift from M. Mack (University of Regensburg, Regensburg, 
Germany). Intracellular FoxP3 staining was performed according to the 
manufacturer’s protocol. Samples were acquired on FACSCalibur (BD Bio-
sciences) and analyzed with CellQuest software (BD Biosciences). Cell 
quantifi cations with counting beads (Caltag) were performed in duplicates of 
50 μl of blood, spleen, and inguinal LNs. Samples were stained with CD4, 
CD25, and FoxP3. Erythrocytes were lysed, and the remaining cells were 
resuspended in 200 μl. After thoroughly mixing with 50 μl of counting 
beads, 15,000 beads were acquired in a FACSCalibur for each sample. The 
number of cells/microliter was calculated as [(number of acquired cells)/
(number of acquired beads)] × (number of beads/microliter).
Immunofl uorescence. 7-μm cryosections were prepared from peripheral 
LNs and ears of WT and CCR7 KO mice. Sections were fi xed in acetone 
followed by 4% buff ered paraformaldehyde, permeabilized with 0.5% Triton 
X-100 in PBS, and incubated fi rst with rat anti–mouse FoxP3 (eBioscience) 
followed by donkey anti–rat AlexaFluor488. Sections were subsequently in-
cubated with rat anti–mouse CD3 and hamster anti–mouse CD11c (both 
obtained from BD Biosciences), which were detected with goat anti–rat 
 AlexaFlour546 and goat anti–hamster AlexaFluor633, respectively. All Alexa-
Fluor conjugates were purchased from Invitrogen. Samples were washed 
 after every antibody incubation step. At the end, sections were mounted 
with Vectashield containing DAPI (Vector Laboratories) and studied under 
a confocal microscope (Axiovert LSM; Carl Zeiss MicroImaging, Inc.).
Cell isolations and adoptive transfer. Cell suspensions from spleens were 
produced with cell strainers (BD Biosciences) followed by erythrocyte lysis. 
CD4+ cells were isolated with the negative CD4 isolation kit (Miltenyi 
Biotec) according to the manufacturer’s protocol. Afterward, CD4+ cells were 
stained with CD25-PE mAb (clone PC61; BD Biosciences) for 30 min, 
which was followed by incubation with anti-PE microbeads (Miltenyi Biotec). 
Labeled cells were then run over an LS column followed by an MS column, 
and the positive fraction was eluted. 90% purity was routinely achieved with 
this procedure. Cells were counted and labeled with CFSE (Invitrogen). 
0.5 × 106 cells/population were injected i.v. into BALB/c mice.
In vitro suppression assays. CD4+ T cells and CD4+ CD25+ T reg cells 
were isolated as described in the previous section. CD4+ T cells were labeled 
with CFSE, and 75,000 cells were incubated with 25,000, 50,000, or 75,000 
T reg cells from either WT or CCR7 KO mice in a 96-well round-bottom 
plate. To induce the optimal proliferation of CD4+ T cells by 0.5 μg/ml 
anti-CD3 (clone 145-2c11; BD Biosciences), 20,000 B cells were added to 
each well.
IDB model. Splenic CD4+ CD25neg (Th cells) and CD4+ CD25+ T cells 
(T reg cells) from WT and CCR7 KO mice were isolated by FACS (FACS Aria; 
BD Biosciences). Sorted cells were >98% pure, and 2 × 105 cells of CD4+ 
and/or 105 (2:1 ratio) or 2 × 105 (1:1 ratio) CD4+ CD25+ cells were in-
jected i.v. into recipient SCID mice. Body weight was monitored through-
out the experiment. Studies were terminated 33 d after the T cell transfer. 
Descending colons of mice were fi xed in 4% buff ered paraformaldehyde, 
embedded in paraffi  n, and processed for histology. Individual sections were 
scored blind according to the following independent criteria: epithelial dam-
age (0–2), architectural changes (0–2), neutrophil infi ltration (0–2), mono-
nuclear cell infi ltrate (0–2), ulceration (0 and 1), and granuloma formation 
(0 and 1).
Statistics. All data are presented as mean values ± SEM. The area under the 
curve was calculated and compared with a Student’s t test. Last data points of 
IBD weight curves were analyzed using one-way analysis of variance with 
Dunnett’s correction using data from normal nontransferred mice as a 
control. Histological scores were evaluated by one-way analysis of variance 
with Bonferroni correction for multiple comparisons.
Online supplemental material. Fig. S1 demonstrates increased ex vivo 
antigen-induced T cell proliferation of CCR7 KO mice. Fig. S2 gives 
absolute numbers as well as ratios of diff erent leukocyte populations 
within SLOs of WT and CCR7 KO mice. Fig. S3 shows that the num-
bers of FoxP3+ T reg cells in the thymus and their positioning in the 
medulla are similar in CCR7 KO and WT mice, whereas their distribu-
tion in the cortex is not. Fig. S4 depicts examples of the histological ap-
pearance of descending colons from diff erent groups of the IBD model. 
Online supplemental material is available at http://www.jem.org/cgi/content/
full/jem.20061405/DC1.
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